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Abstract: Zinc chloride is an important inorganic compound used as a source of zinc in various pharmaceutical/nutraceutical 
formulations. The objective of the current study was to investigate the impact of The Trivedi Effect® - Energy of 
Consciousness Healing Treatment (Biofield Energy Treatment) on physical, structural, thermal, and behavioral properties of 
zinc chloride using PXRD, PSD, FT-IR, UV-vis, and DSC analysis. Zinc chloride was divided into two parts – one part was 
control, while another part was treated with The Trivedi Effect® remotely by twenty renowned Biofield Energy Healers and 
defined as The Trivedi Effect® Treated sample. A significant alteration of the crystallite size and relative intensities of the 
PXRD peaks was observed in The Trivedi Effect® treated sample compared with the control sample. The average crystallite 
size of the treated sample was significantly decreased by 16.31% compared with the control sample. The particle size values at 
d10, d50, and d90 were significantly decreased by 11.54%, 7.75%, and 1.34%, respectively in the treated sample compared with 
the control sample. Therefore, the surface area of the treated sample was significantly increased by 8.36% compared with the 
control sample. The FT-IR spectroscopic analysis revealed that Zn-Cl stretching in both the control and treated samples were 
found at 516 cm-1. The UV-vis analysis exhibited that wavelength of the maximum absorbance (λmax) of the control and treated 
samples were at 196.6 nm and 196.4 nm, respectively. The DSC analysis exhibited that the melting and decomposition 
temperature were increased by 1.25% and 0.21%, respectively in the treated zinc chloride compared to the control sample. The 
latent heat of fusion of the treated sample (434.97 J/g) was significantly increased by 84.74% compared with the control 
sample (235.45 J/g). Similarly, the enthalpy of decomposition of the treated sample (1241.86 J/g) was significantly increased 
by 307.21% compared with the control sample (304.97 J/g). So, the treated sample could be more stable during manufacturing, 
delivery or storage conditions than the untreated sample. The current study anticipated that The Trivedi Effect® - Energy of 
Consciousness Healing Treatment might lead to produce a thermally more stable new polymorphic form of zinc chloride, 
which would be more soluble and bioavailable compared with the untreated compound. Hence, the treated zinc chloride would 
be very useful to design better nutraceutical/pharmaceutical formulations that might offer better therapeutic response against 
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inflammatory diseases, immunological disorders, aging, stress, cancer, etc. 
Keywords: Zinc Chloride, The Trivedi Effect®, Consciousness Energy Healing Treatment,  
Biofield Energy Healing Treatment, Biofield Energy Healers, PXRD, Particle Size, DSC 
 
1. Introduction 
Zinc is an essential element in human body due to its 
broad spectrum of physiological functions. It plays an 
important role in catalytic, structural or regulation in 
enzymes in the body, which involved in the nucleic acid and 
protein metabolism as well as for the production of energy. 
Zinc also maintains the structural integrity of the biological 
membranes resulting in their protection against oxidative 
injury [1-2]. As a metallotherapeutic agent, zinc possesses 
various pharmacological activities include fertility 
enhancing, retino-protective, and putative antiviral activities 
[3]. Zinc is also used in the treatment of Wilson’s disease [4]. 
It has also immunomodulatory and antioxidant activities [1]. 
Zinc is also used to prevent the development of several 
deficiency symptoms include parakeratosis, hypogeusia, 
anorexia, dysosmia, geophagia, hypogonadism, growth 
retardation, etc. [5-7]. Recently, it has been reported that zinc 
had increased the leukocyte count and phagocytic index, 
which potentiate the immunomodulatory effect along with 
Glycyrrhiza glabra [8]. Zinc chloride (ZnCl2) is hygroscopic 
inorganic salt and highly soluble in water [9]. It is used in 
pharmaceutical industry as drug and diagnostic agent due to 
its powerful astringent and mild antiseptic properties [10]. It 
is also used in mouth-wash and deodorant preparations. Zinc 
chloride is used as dentin desensitizer i.e. reduces the 
sensitivity of the teeth to heat and cold. The other 
applications of zinc chloride include protein precipitation and 
insulin preparation [10, 11]. Literature reported that zinc 
chloride has also been used in the treatment of cancer as a 
destructive agent [12] and in the pluripotency maintenance of 
mouse embryonic stem cell through the regulation of STAT3 
signaling pathway [13]. It can be used for the palliative 
treatment of canine and malignant skin wounds [14]. It has 
the opposite effect on locomotor behavior of rats [15]. 
Therefore, zinc chloride was considered as one of the 
components in the novel proprietary herbomineral 
formulation for the source of zinc ion. This herbomineral 
formulation is designed as nutraceutical supplement and can 
be used for the prevention and treatment of various human 
disorders. 
An élan vital or vital force which contributes the ‘life’ is 
preserved by every living organisms and known as prana by 
the Hindus, qi or chi by the Chinese, and ki by the Japanese. 
This is believed to co-relate with the soul, spirit and mind. 
This hypothetical vital force is considered as the Biofield 
Energy. The Biofield Energy is infinite, paradimensional and 
dynamic electromagnetic field surrounding the human body. 
It can freely flow between the human and environment that 
leads to the continuous movement or matter of energy [16, 
17]. Thus, a human has the ability to harness energy from the 
earth, the “universal energy field” and transmit it to any 
living or nonliving object(s) around the globe. The objects 
always receive the energy and respond in a useful way. This 
process is known as Biofield Energy Healing Treatment [18, 
19]. Biofield (Putative Energy Fields) based Energy 
Therapies are used worldwide to promote health and healing. 
The National Center of Complementary and Integrative 
Health (NCCIH) has been recognized and accepted Biofield 
Energy Healing as a Complementary and Alternative 
Medicine (CAM) health care approach in addition to other 
therapies, medicines and practices such as natural products, 
deep breathing, yoga, Tai Chi, Qi Gong, 
chiropractic/osteopathic manipulation, meditation, massage, 
special diets, homeopathy, progressive relaxation, guided 
imagery, acupressure, acupuncture, relaxation techniques, 
hypnotherapy, healing touch, movement therapy, pilates, 
rolfing structural integration, mindfulness, Ayurvedic 
medicine, traditional Chinese herbs and medicines, 
naturopathy, essential oils, aromatherapy, Reiki, cranial 
sacral therapy and applied prayer (as is common in all 
religions, like Christianity, Hinduism, Buddhism and 
Judaism) [20]. Biofield Energy Treatment (The Trivedi 
Effect®) has been reported in numerous peer-reviewed 
science journals with significant outcomes in many scientific 
fields such as cancer research [21]; altered antimicrobial 
sensitivity of pathogenic microbes in microbiology [22-24], 
biotechnology [25, 26], genetics [27, 28]; changing the 
structure of the atom in relation to various metals, ceramics, 
polymers and chemicals in materials science [29, 30], altered 
physical and chemical properties of pharmaceuticals [31, 32], 
nutraceuticals [33, 34], organic compounds [35-37], and 
improved overall growth and yield of plants in agricultural 
science [38, 39]. The physicochemical properties such as 
particle size, crystalline structure, crystallite size, surface 
area, and thermal properties of a drug have a vital role in 
bioavailability as well as stability of the drug during 
processing, formulation, storage, and packaging [40, 41]. The 
particle size, specific surface area, crystalline nature, 
chemical and thermal behavior of an atom/ion might be 
altered by the Biofield Energy Healing Treatment (The 
Trivedi Effect®) through possible mediation of neutrinos 
[42]. By considering all these aspects, powder X-ray 
diffraction (PXRD), particle size distribution analysis (PSD), 
Fourier transform infrared (FT-IR) spectrometry, ultraviolet-
visible (UV-vis) spectroscopy, and differential scanning 
calorimetry (DSC) analytical techniques were conducted in 
this study for the characterization of physical, structural, and 
thermal properties of the Biofield Energy Treated and 
untreated zinc chloride. 
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2. Materials and Methods 
2.1. Chemicals and Reagents 
Zinc chloride was procured from Tokyo Chemical Industry 
Co., Ltd. (TCI), Japan. All other chemicals used in the 
experiment were of analytical grade available in India. 
2.2. The Trivedi Effect
®
 Energy of Consciousness Healing 
Treatment Strategies 
Zinc chloride was one of the components of the new 
proprietary herbomineral formulation, developed by our 
research team and it was used per se as the test compound for 
the current study. The test compound was divided into two 
parts, one part of the test compound did not receive any sort 
of treatment and was defined as the untreated or control zinc 
chloride sample. The second part of the test compound was 
treated with The Trivedi Effect® - Energy of Consciousness 
Healing Treatment (Biofield Energy Treatment) by a group 
of twenty renowned Biofield Energy Healers remotely and 
was denoted as Biofield Energy Treated or The Trivedi 
Effect® sample. Eighteen Biofield Energy Healers were 
remotely located in the U.S.A. and two of which were 
remotely located in Canada, while the test compound was 
located in the research laboratory of GVK Biosciences Pvt. 
Ltd., Hyderabad, India. This Biofield Energy Treatment was 
provided for 5 minutes through Healer’s Unique Energy 
Transmission process remotely to the test compound under 
the laboratory conditions. None of the Biofield Energy 
Healers in this study visited the laboratory in person, nor had 
any contact with the compounds. Similarly, the control 
compound was subjected to “sham” healers for 5 minutes, 
under the same laboratory conditions. The sham healer did 
not have any knowledge about the Biofield Energy 
Treatment. After that, the Biofield Energy Treated and 
untreated samples were kept in similar sealed conditions and 
characterized thoroughly by PXRD, PSD, FT-IR, UV-visible 
spectroscopy, and DSC analysis. 
2.3. Characterization 
2.3.1. Powder X-ray Diffraction (PXRD) Analysis 
The PXRD analysis was accomplished on PANalytical 
X’pert Pro powder X-ray diffractometer system. The X-ray 
of wavelength 1.54056 Å was used. The data was collected in 
the form of a chart of the Bragg angle (2θ) vs. intensity, and a 
detailed table containing information on peak intensity 
counts, d value (Å), relative intensity (%), full width half 
maximum (FWHM) (θ°). From the PXRD results, the 
crystallite size (G) was calculated using X’pert data collector 
and X’pert high score plus processing software. The 
crystallite size (G) was calculated from the Scherrer equation 
[43, 44]. The method was based on the width of the 
diffraction patterns obtained in the X-ray reflected the 
crystalline region. The crystallite size (G) was calculated by 
using the following equation 1: 
G = kλ/(bCosθ)                                  (1) 
Where, k is the equipment constant (0.5), λ is the X-ray 
wavelength (0.154 nm); b in radians is the full-width at half 
of the peaks and θ the corresponding Bragg angle. 
Percent change in crystallite size (G) was calculated using 
following equation 2: 
%	change	in	crystallite	size	 =
		
	
× 100  (2) 
Where, GControl and GTreated are the crystallite size of the 
control and Biofield Energy Treated samples, respectively. 
A total of ~500 mg of the control and Biofield Energy 
Treated samples individually were used for the analysis and 
prepared by back loading technique using the sample 
preparation kit. The sample was spread on the holder ring in 
sufficient quantity to fill the ring cavity. It was then pressed 
down using powder press block and scrap the powder that 
was in surplus using a glass slide to get densely packed 
specimen. Consequently, the bottom plate was placed onto 
the holder ring and clamp in position. The sample holder was 
then removed from the sample preparation table by turning it 
upside down. A smooth surface of sample was obtained to 
ensure optimum results. 
2.3.2. Particle Size Distribution (PSD) Analysis 
The average particle size and particle size distribution 
were analyzed using Malvern Mastersizer 2000, UK with a 
detection range between 0.01 µm to 3000 µm. The sample 
unit was filled with the dispersant medium and operated the 
stirrer at 2500 rpm. Alignment of the optics was done and the 
background measurement was taken. After the background 
measurement, the sample was added into the sample unit 
with constant monitoring the obscuration and stopped the 
addition of sample when the obscuration reached in between 
15% to 20%. When the obscuration was stable, the 
measurement was taken twice and the average of two 
measurements was taken. The average histogram of the two 
measurements was recorded. The data was presented in table 
format which include particle size (µm). Also, the values at 
below 10% level (d10), 50% level (d50), and 90% level (d90) 
were calculated from the histogram and the calculations such 
as surface area (m2/g) were done by using software 
Mastersizer 2000. 
Percent change in particle size (d) for at below 10% level 
(d10), 50% level (d50), and 90% level (d90) was calculated 
using following equation 3: 
%	change	in	particle	size =
##
#
× 100                                                 (3) 
Where, dControl and dTreated are the particle size (µm) for at below 10% level (d10), 50% level (d50), and 90% level (d90) of the 
control and Biofield Energy Treated samples, respectively. 
Percent change in surface area (S) was calculated using following equation 3: 
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%	change	in	surface	area =
&	&	
&	
× 100                                                   (4) 
Where, SControl and STreated are the surface area of the 
control and Biofield Energy Treated samples, respectively. 
2.3.3. Fourier Transform Infrared (FT-IR) Spectroscopy 
FT-IR spectroscopy of zinc chloride was performed on 
Spectrum two (Perkin Elmer, USA) Fourier transform 
infrared spectrometer with the frequency array of 400-4000 
cm-1 by using pressed KBr disk technique. 
2.3.4. Ultraviolet-Visible Spectroscopy (UV-Vis) Analysis 
The UV-Vis spectral analysis was carried out using 
Shimadzu UV-2450 with UV Probe, Japan. The spectrum 
was recorded using 1 cm quartz cell that has a slit width of 
1.0 nm. The wavelength range chosen for recording the 
spectra was 190-800 nm. The absorbance spectra (in the 
range of 0.2 to 0.9) and wavelength of maximum absorbance 
(λmax) were recorded. 
2.3.5. Differential Scanning Calorimetry (DSC) 
Analysis was performed using the DSC Q20 (TA 
Instruments, USA) differential scanning calorimeter. A total 
of ~7.5 mg sample was weighed and sealed in aluminum 
pans and equilibrated at 25°C and heated up to 450°C at the 
heating rate of 10ºC/min under nitrogen gas as purge 
atmosphere with flow rate of 50 mL/min. The value for 
onset, endset, peak temperature, peak height (mJ or mW), 
peak area, and change in heat (J/g) for each peak were 
recorded. 
Percent change in the decomposition temperature (T) was 
calculated using following equation 4: 
%	change	in	decomposition	temperature =
**
*
× 100                                    (5) 
Where, TControl and TTreated are the decomposition temperature of the control and Biofield Energy Treated samples, 
respectively. 
Percent change in the enthalpy of decomposition (∆H) was calculated using following equation 5: 
%	change	in	latent	heat	of	fusion =
∆,-,
-,
× 100                                        (6)
Where, ∆HControl and ∆HTreated are the enthalpy of 
decomposition of the control and Biofield Energy Treated 
samples, respectively. 
3. Results and Discussion 
3.1. Powder X-ray Diffraction (PXRD) Analysis 
The PXRD diffractograms of both the control and Biofield 
Energy Treated zinc chloride are shown in the Figure 1. Both 
the samples displayed very sharp and intense peaks in their 
respective diffractogram indicating the crystalline nature of 
zinc chloride. PXRD data such as Bragg angle (2θ), relative 
intensity (%), full width half maximum (FWHM) (θ°), and 
crystallite size (G) for the control and Biofield Energy 
Treated zinc chloride are presented in the Table 1. The 
crystallite size was calculated with the help of Scherrer 
equation [43, 44]. The crystallite size of the control and 
Biofield Energy Treated samples were found to be similar at 
2θ equal to nearly 25.4° (Table 1, entry 3). Whereas, the 
crystallite size of the Biofield Energy Treated zinc chloride at 
2θ equal to nearly 15.6°, 34.9°, 48.6°, 63.1°, and 90.8° (Table 
1, entry 1, 5, 8, 14, and 20) was significantly increased in the 
range of 33.25% to 100% compared with the control sample. 
Consequently, at 2θ equal to 15.6°, 29.3°, 38.3°, 44.9°, 49.2°, 
52.3°, 56.2°, 58.3°, 61.8°, 66.2°, 72.1°, 74.6°, 78.9°, 84.8°, 
and 91.9° (Table 1, entry 2, 4, 6, 7, 9-13, 15-19, 21), the 
crystallite size of the Biofield Energy Treated zinc chloride 
was significantly decreased from 16.68% to 59.04% with 
respect to the control sample. However, the average 
crystallite size of the Biofield Energy Treated sample was 
significantly decreased by 16.31% (Table 1, entry 22) with 
respect to the control sample. 
Table 1. PXRD data of the control and Biofield Energy Treated zinc chloride. 
Entry No 
Bragg angle (°2θ) Relative Intensity (%) FWHM (°2θ) Crystallite size (G, nm) 
Control Treated  Control Treated  Control Treated  Control Treated  % change* 
1 15.61 15.54 90.60 23.81 0.1171 0.0836 37.94 53.14 40.06 
2 16.58 16.48 28.68 9.48 0.0502 0.1004 88.61 44.30 -50.01 
3 25.43 25.31 100.00 35.35 0.0669 0.0669 67.45 67.44 -0.02 
4 29.28 29.16 80.57 28.17 0.0669 0.1020 68.01 44.59 -34.43 
5 34.91 34.86 56.60 46.69 0.0669 0.0502 68.98 91.92 33.25 
6 38.28 38.14 38.34 40.32 0.0502 0.0836 92.83 55.72 -39.98 
7 44.91 44.83 13.76 5.32 0.1338 0.2007 35.61 23.73 -33.35 
8 48.60 48.58 59.22 56.59 0.1338 0.0816 36.11 59.21 63.96 
9 49.16 49.11 82.29 100.00 0.0669 0.0816 72.38 59.33 -18.03 
10 52.27 52.16 21.64 12.80 0.0836 0.2040 58.68 24.04 -59.04 
11 56.17 56.09 35.32 34.57 0.1171 0.2040 42.63 24.46 -42.62 
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Entry No 
Bragg angle (°2θ) Relative Intensity (%) FWHM (°2θ) Crystallite size (G, nm) 
Control Treated  Control Treated  Control Treated  Control Treated  % change* 
12 58.34 58.19 99.92 25.30 0.0816 0.1020 61.82 49.42 -20.06 
13 61.78 61.62 42.96 14.21 0.0612 0.0816 83.88 62.85 -25.06 
14 63.10 63.10 18.01 15.88 0.1224 0.0612 42.23 84.47 100.00 
15 66.22 66.11 21.01 8.45 0.0816 0.1224 64.46 42.95 -33.38 
16 72.13 72.11 32.04 16.37 0.1020 0.1224 53.45 44.53 -16.68 
17 74.64 73.63 16.12 5.53 0.0612 0.1224 90.55 44.97 -50.33 
18 78.95 78.87 15.37 14.36 0.0816 0.1224 69.98 46.63 -33.37 
19 84.77 84.70 14.53 5.91 0.1224 0.1632 48.77 36.56 -25.04 
20 90.79 90.68 14.87 8.81 0.1224 0.0816 51.32 76.90 49.85 
21 91.93 91.85 29.13 23.77 0.0816 0.1020 77.77 62.17 -20.06 
22 Average crystallite size 62.55 52.35 -16.31 
 
Figure 1. PXRD diffractograms of the control and Biofield Energy Treated zinc chloride. 
FWHM: Full width half maximum, *denotes the 
percentage change in the crystallite size of the Biofield 
Energy Treated sample with respect to the control sample. 
The PXRD diffractogram of the Biofield Energy Treated 
zinc chloride displayed greater intensity at Bragg’s angle (2θ) 
equal to 49.11° (Table 1, entry 9), whereas it was found at 
25.43° (Table 1, entry 3) in the control sample. Beside this, 
the relative intensities of the PXRD peaks (Table 1) in the 
Biofield Energy Treated sample were significantly changed 
compared with the control sample. XRD relative intensity of 
each diffraction face on crystalline compound changes 
according to crystal morphology [45]. Thus, it is presumed 
that the energy transferred through the Biofield Energy 
Healing probably changed the shape and size of molecules of 
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the Biofield Energy Treated sample that might be the 
responsible for an alteration in relative intensities and 
crystallite size in the Biofield Energy Treated sample as 
compared to the control sample. 
Raza et al. reported that changes in XRD pattern provide 
the proof of polymorphic transitions [46, 47]. Crystal habit, 
size, and even polymorphic form of a drug have a significant 
effect on the drug solubility, dissolution, and bioavailability. 
It has been reported in the literature that alteration in the 
crystal morphology had the significant impact on in vitro 
dissolution rate, with prospective for improving 
bioavailability [41]. Hence, PXRD study revealed that the 
Biofield Energy Healing Treatment might introduced a new 
polymorphic form of zinc chloride, which could have 
improved bioavailability compared with the control sample. 
3.2. Particle Size Distribution (PSD) Analysis 
The particle size values (d10, d50, and d90) and the average 
surface area of the control and Biofield Energy Treated zinc 
chloride were investigated and the results are presented in the 
Table 2. It was evident that the Biofield Energy Treatment 
has the ability to reduce the particle size (d10, d50, and d90) of 
zinc chloride with respect to the control sample. The size of 
the particles at below 10% level (d10), 50% level (d50), and 
90% level (d90) were decreased by 11.54%, 7.75%, and 
1.34%, respectively in the Biofield Energy Treated sample 
compared to the control sample. 
Table 2. Particle size data (d10, d50, and d90) and surface area of the control 
and Biofield Energy Treated zinc chloride. 
Parameter 
d10 
(µm) 
d50 
(µm) 
d90 
(µm) 
Surface 
area (m
2/g) 
Control 1.04 2.71 5.95 2.99 
Biofield Energy Treated 0.92 2.50 5.87 3.24 
Percent change (%)* -11.54 -7.75 -1.34 8.36 
*denotes the percentage change in the particle size data (d10, d50, and d90) and 
surface area of the Biofield Energy Treated sample with respect to the 
control sample. 
The particle size and surface area have a major effect on 
dissolution of a compound in a solvent, because the surface 
energy influenced by the surface area and chemical affinity is 
the driving factor for dissolution efficiency [48, 49]. The 
surface area for both the control and Biofield Energy Treated 
zinc chloride samples were analyzed and the results are 
presented in Table 2. The control sample showed surface area 
of 2.99 m2/g and it was increased to 3.24 m2/g in the Biofield 
Energy Treated zinc chloride. The surface area of the 
Biofield Energy Treated sample significantly increased by 
8.36% compared with the control sample.  
Poorly crystallized compounds possess more surface area 
and higher exchange capacities than well-crystallized 
compounds [50]. In addition, the variation of the crystal 
morphology in the Biofield Energy Treated sample, which 
was well-supported from PXRD data, may cause to alter the 
surface area of the Biofield Energy Treated zinc chloride 
compared with the control sample. It has been well 
established that the particle size, shape and surface area of 
pharmaceutical compounds have an important impact on 
solubility, dissolution and in vivo bioavailability, as well as 
supports the designing of new drug delivery systems [51, 52]. 
Reducing the particle size and higher surface area would 
enhance the solubility of the solid particles, and consequently 
would increase the dissolution rate and bioavailability [53]. 
Thus, it is assumed that the Biofield Energy Treated zinc 
chloride might be dissolved and absorbed at a faster rate and 
may possibly have more bioavailability than untreated zinc 
chloride. 
3.3. Fourier Transform Infrared (FT-IR) Spectroscopy 
The FT-IR spectra of the control and Biofield Energy 
Treated samples of zinc chloride are presented in the Figure 
2. The characteristic peak were observed at 3589, 3519, 
1931, 1608, 991, and 516 cm-1 in the control FT-IR spectrum 
(Figure 2). On the other hand, the FT-IR spectrum of the 
Biofield Energy Treated zinc chloride showed the notable 
absorption bands at 3589, 3519, 1931, 1608, 991, and 516 
cm-1 (Figure 2). The strong and broad absorption band 
centered near 3589 cm-1 and the H-O-H bending motion at 
1607 cm-1 that were due to the presence of the lattice water 
were found in the FT-IR spectrum of both the control and 
Biofield Energy Treated samples (Figure 2). Literature 
suggested that the metal-halide stretching absorption band for 
inorganic materials generally found in the 750-100 cm-1 
region [54]. Both the FT-IR spectrum of the control and 
Biofield Energy Treated samples showed the metal-halide 
(Zn-Cl) stretching at 516 cm-1. Overall, the characteristic 
molecular vibrational frequencies of the Biofield Energy 
Treated zinc chloride were not significantly changed 
compared with the control sample. 
3.4. Ultraviolet-visible Spectroscopy (UV-Vis) Analysis 
The UV-visible spectra of both the control and Biofield 
Energy Treated zinc chloride are presented in the Figure 3. 
The wavelength of the most intense UV-Vis absorbance 
(λmax) of both the control and Biofield Energy Treated 
samples were observed in their UV-Vis spectra (Figure 3) at 
196.6 and 196.4 nm, respectively with a minor shift of 
absorbance maxima from 1.9184 in the control sample to 
1.8619 in the Biofield Energy Treated sample. The UV 
absorbance occurs due to the diverse type of energy 
transitions from the singlet to the singlet excited state such as 
σ → σ∗, n → π∗, and π → π∗. These type of electronic 
transitions are occurred when the difference in energy 
between the lowest unoccupied molecular orbital (LUMO) 
and the highest occupied molecular orbital (HOMO) is 
significantly higher than the activation energy of the 
compound [55]. The UV-vis spectroscopic analysis of zinc 
chloride displayed no change in the λmax of the Biofield 
Energy Treated sample as compared to the control sample. 
Thus, the structural configuration or activation energy of the 
Biofield Energy Treated sample was not changed compared 
to the control sample. 
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Figure 2. FT-IR spectra of the control and biofield energy treated zinc chloride. 
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Figure 3. UV-vis spectra of the control and biofield energy treated zinc chloride. 
3.5. Differential Scanning Calorimetry (DSC) Analysis 
The DSC thermograms of the control and Biofield Energy 
Treated zinc chloride are presented in the Figure 4. The 
melting/decomposition temperature and enthalpy of 
fusion/decomposition of the control and Biofield Energy 
Treated zinc chloride are presented in the Table 3. The 
melting/fusion temperature was increased by 1.25% in the 
Biofield Energy Treated zinc chloride (314.82°C) compared 
with the control sample (310.94°C). The onset melting 
temperature was decreased by 1.88% and the endset 
temperature was increased by 0.99% in the Biofield Energy 
Treated sample compared with the control sample. The latent 
heat of fusion or enthalpy of fusion (∆Hfusion) of the control 
and Biofield Energy Treated zinc chloride was 235.45 J/g and 
434.97 J/g, respectively. The ∆Hfusion of the Biofield Energy 
Treated sample was significantly increased by 84.74% 
compared with the control sample. Similarly, the 
decomposition temperature of the Biofield Energy Treated 
zinc chloride (385.38°C) was increased by 0.21% compared 
to the control sample (384.56°C). The onset decomposition 
temperature was decreased by 0.23%; whereas, the endset 
temperature was increased by 0.90% in the Biofield Energy 
Treated sample compared with the control sample. The 
enthalpy of decomposition (∆Hdecomposition) of the control and 
Biofield Energy Treated zinc chloride were 304.97 J/g and 
1241.86 J/g, respectively. The ∆Hdecomposition of the Biofield 
Energy Treated sample was significantly increased by 
307.21% compared with the control sample. This results 
indicated that the zinc chloride need more energy in the form 
of latent heat to undergo the process of melting after Biofield 
Energy Treatment. It is anticipated that Biofield Energy 
Treatment might enhance the internal energy in zinc chloride 
that leads to increase of the melting/decomposition 
temperature and the enthalpy of fusion/decomposition and 
ultimately to enhance the thermal stability of the Biofield 
Energy Treated sample significantly compared with the 
untreated sample. The enhanced thermal stability of a drug is 
an advantage in the maintenance of the product in long term 
storage condition throughout the shelf-life for any 
pharmaceutical formulations [56]. 
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Table 3. The latent heat of fusion (J/g), enthalpy of decomposition (J/g) and melting/decomposition temperature (°C) values of the control and Biofield Energy 
Treated zinc chloride. 
Endothermic peak Description Tonset (°C) Tpeak (°C) Tendset (°C)  ∆H (J/g) 
Endothermic peak 
Control sample 297.77 310.94 315.78 235.45 
Biofield Energy Treated sample 303.37 314.82 318.91 434.97 
% Change* -1.88 1.25 0.99 84.74 
Exothermic peak 
Control sample 380.85 384.56 384.60 304.97 
Biofield Energy Treated sample 379.97 385.38 388.07 1241.86 
% Change* -0.23 0.21 0.90 307.21 
Tonset:
 Onset melting/decomposition temperature, Tpeak: Peak melting/decomposition temperature, Tendset: Endset melting/decomposition 
temperature, ∆H: Enthalpy of fusion/decomposition, *denotes the percentage change of the Biofield Energy Treated sample with respect to the control 
sample. 
 
Figure 4. DSC thermograms of the control and Biofield Energy Treated zinc chloride. 
4. Conclusions 
The current study revealed that The Trivedi Effect® - Energy 
of Consciousness Healing Treatment had the significant effects 
on the physical, structural, thermal, and behavioral properties of 
zinc chloride. The PXRD data displayed the significant 
alteration of the crystallite size and relative intensities of the 
PXRD peaks in The Trivedi Effect® treated sample compared 
with the control sample. The average crystallite size of the 
treated sample was significantly decreased by 16.31% compared 
with the control sample. The particle size values at d10, d50, and 
d90 were significantly decreased by 11.54%, 7.75%, and 1.34%, 
respectively in the treated sample compared with the control 
sample. Therefore, the surface area of the treated sample was 
significantly increased by 8.36% compared with the control 
sample. The DSC analysis exhibited that the melting and 
decomposition temperature were increased by 1.25% and 
0.21%, respectively in the treated zinc chloride compared to the 
control sample. The latent heat of fusion of the treated sample 
was significantly increased by 84.74% compared with the 
control sample. Similarly, the enthalpy of decomposition of the 
treated sample was significantly increased by 307.21% 
compared with the control sample. The thermal analysis 
revealed that the zinc chloride need more energy in the form of 
latent heat to undergo the process of melting and decomposition 
after Biofield Energy Treatment. Thus, the treated sample could 
be more stable during manufacturing, delivery or storage 
conditions than the untreated sample. Briefly, The Trivedi 
Effect® - Energy of Consciousness Healing Treatment might 
introduce a new thermally stable polymorphic form of zinc 
chloride that could be more soluble and bioavailable compared 
with the untreated compound. Hence, Biofield Energy Treated 
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zinc chloride would be very useful to design better nutraceutical 
and/or pharmaceutical formulations that might offer better 
therapeutic response against inflammatory diseases, 
immunological disorders, aging, stress, cancer, Wilson’s disease, 
viral diseases, parakeratosis, hypogeusia, anorexia, dysosmia, 
geophagia, hypogonadism, growth retardation, etc. 
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